Help us to stop bowel cancer

Genetic conditions in colorectal cancer - study day

This study day will cover an overview of common and rare genetic syndromes contributing to colorectal cancer, testing and diagnosis, treatment, prevention and psychosocial effects.

Featuring a panel of expert speakers, the day is aimed at research nurses, CNS, oncology nurses and other colorectal cancer healthcare professionals with an interest in genetics.

The day is free to attend, but registration is essential

  • Date: 24 November 2017
  • Time: 9am-5pm
  • Location: Liner Hotel, Liverpool

 

Click here to download the official flyer for the study day

Click here to download the official programme for the study day


More details, including the programme for the day, to be released. Please register your interest below. 

Genetic conditions in colorectal cancer - study day

We will never sell or swap your information with other organisations. You are free to change your information and preferences at any time by emailing admin@bowelcanceruk.org.uk or calling 020 7940 1760 and our privacy policy is here.

“This was a very informative conference and a useful update that will help me to inform patients effectively. It was thoroughly interesting, the speakers were incredible and the information given extremely helpful. Would recommend to fellow colleagues.” Previous attendee

 

 

This meeting has been sponsored by Amgen

This meeting has been supported financially by Servier Laboratories Ltd

Norgine has provided financial support for this meeting

 

Bristol-Myers Squibb has provided financial support for this meeting

Merck has provided financial support for this meeting

None of the meeting sponsors have had input into the content or speaker selection

We are determined to save lives from bowel cancer but we can’t do this without you. Support vital research and lifesaving work to stop bowel cancer.
We are determined to save lives from bowel cancer but we can’t do this without you. Support vital research and lifesaving work to stop bowel cancer.